Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reduced complement-mediated immune complex solubilization in leprosy patients.

V D Ramanathan, P Sharma, G Ramu

    Clinical and Experimental Immunology
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of Prothionamide on the Infectivity of Lepromatous Leprosy.

    Indian journal of dermatology, venereology and leprology·2017
    Same author

    Ten-year Study of Lepromin Response in Child Contacts of Leprosy Patients.

    Indian journal of dermatology, venereology and leprology·2017
    Same author

    Antioxidant Studies on Ethanol Extracts from Two Selected Genera of Indian Lamiaceae.

    Indian journal of pharmaceutical sciences·2016
    Same author

    Neural pathology in leprosy during treatment and surveillance.

    Leprosy review·2004
    Same author

    Reactions in borderline leprosy.

    Indian journal of leprosy·2003
    Same author

    Chromosomal aberration, micronucleus and Comet assays on peripheral blood lymphocytes of leprosy patients undergoing multidrug treatment.

    Mutagenesis·2002
    Same journal

    Could we discuss the molecular signature of immune dysregulation?

    Clinical and experimental immunology·2026
    Same journal

    The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

    Clinical and experimental immunology·2026
    Same journal

    PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

    Clinical and experimental immunology·2026
    Same journal

    Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

    Clinical and experimental immunology·2026
    Same journal

    Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

    Clinical and experimental immunology·2026
    Same journal

    Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

    Clinical and experimental immunology·2026
    See all related articles

    Leprosy patients undergoing reactions show reduced immune precipitate solubilization via complement. This capacity remained low even after reactions subsided, unlike immune complexes and C3d levels.

    Area of Science:

    • Immunology
    • Complement System
    • Leprosy Pathogenesis

    Background:

    • The complement system plays a crucial role in immune complex clearance.
    • Leprosy, a complex infectious disease, involves dysregulation of the immune response.
    • Impaired immune complex solubilization may contribute to disease pathology in leprosy.

    Purpose of the Study:

    • To investigate the in vitro immune precipitate solubilization capacity of sera from leprosy patients.
    • To correlate solubilization ability with clinical status, particularly during leprosy reactions.
    • To assess the dynamics of solubilization following chemotherapy and reaction subsidence.

    Main Methods:

    • Sera from leprosy patients and healthy controls were analyzed for immune precipitate solubilization.

    Related Experiment Videos

  • Complement-mediated solubilization was assessed in vitro.
  • Total and alternative pathway hemolytic activity were measured.
  • Circulating immune complexes and serum C3d levels were monitored.

    • Main Results:

    • Sera from leprosy patients in reaction exhibited significantly decreased solubilization capacity compared to healthy controls.
    • Patients with no reactions after chemotherapy showed normal solubilization levels.
    • Decreased solubilization during reaction did not correlate with total or alternative pathway hemolytic activity.
    • Solubilization remained low for 3 months post-reaction, despite reductions in immune complexes and C3d.

    Conclusions:

    • Reduced complement-mediated immune precipitate solubilization is a feature of leprosy reactions.
    • This impairment persists even after clinical resolution of reactions.
    • The findings suggest a potential role for impaired solubilization in leprosy pathogenesis and chronicity.